# FDA recall D-0575-2025

> **Pfizer** · Class II · drug recall initiated 2025-07-29.

## Product

Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.

## Reason for recall

Subpotent drug

## Distribution

Within U.S

## Key facts

- **Recall number:** D-0575-2025
- **Recalling firm:** Pfizer
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-07-29
- **Report date:** 2025-08-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Manhattan, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0575-2025

## Citation

> AI Analytics. FDA recall D-0575-2025. Retrieved 2026-06-04 from https://api.ai-analytics.org/recall/D-0575-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*